The size of the global needles market was worth USD 6.72 billion in 2021. This value is further estimated to be growing at a CAGR of 7.7% and grow to USD 10.49 billion by 2027.
The Market is showing tremendous growth potential during the forecast period. It will continue to expand with the recent developments in the pharmaceutical industry. Continuous advancements in the medical profession to minimize the rising cost of healthcare and the increasing prevalence of diseases worldwide have made needles an essential part of today's healthcare ecosystem. Furthermore, COVID-19 circumstances are quickly improving the industry. Therefore, the needle market is constantly expanding and will continue to do so.
Needles are combined with infusions to deliver medicines to the body and are used for many purposes, such as blood processing, dental procedures, and surgical procedures. It fits into the syringe's portion and is divided into three sections: long shaft, incline, and middle. Different types of needles are often used in clinical practice for various purposes, such as drug administration within various layers of skin, aesthetic procedures, and different surgical procedures. Therefore, there are various types of needles available.
Conventional needles are used for general medicine administration, and fill and filter needles are used for vaccination and other sterile products. In contrast, safety needles are used for blood collection and to prevent infections through contamination during medication administration. It also depends on its application area; for instance, pen needles are used by diabetes patients for injecting a daily dose of insulin. In addition, blood collection needle is used for diagnostic purposes, and suture needles are used for surgical purposes.
The rising adoption of injectable drugs, increasing demand for vaccines, rising medical costs, and growing demand for hormonal supplements are the global growth factors of the needles market.
According to the United Nations Children's Fund (UNICEF), in 2018, global coverage rates for the third dose of the diphtheria-tetanus-pertussis (DTP3) vaccine reached 87% from 74% in 2002 was 22% in 1985. Yet 72 countries have yet to meet the Global Vaccine Action Plan (GVAP) target of 92% or more DTP3 coverage. In addition, due to the advantages of injectable drugs over tablet formulations, companies focus on developing injectable drug delivery systems, including syringes and needles.
The increase in the geriatric population and the demand for vaccines are other primary growth factors in the global needles market.
By 2030, approximately 1.4 billion worldwide are expected to be more than 60 years old, according to World Health Organization (WHO). The increasing prevalence of various chronic diseases and the rising number of hospitals and clinics in emerging countries are also expected to accelerate the growth of the needles market during the forecast period. Centers for Disease Control and Prevention (CDC) says six out of 10 Americans suffer from at least one chronic condition. The extensive R&D of leading companies worldwide to introduce needle technology with maximum safety and precision is expected to expand. In January 2018, a research team from the University of Adelaide developed a biopsy needle attached to a small imaging probe to allow surgeons to assess particular blood vessels at risk when inserting the needle, thus preventing fatal bleeding.
Additionally, the emergence of needle technology reduces the pain and anxiety experienced during injections. Specific treatment regimens are associated with pain and anxiety, where various psychological and physical factors activate pain receptors in the brain. For instance, there is a strong association between pain and anxiety and dental injection during dental procedures. Moreover, increased blood donation awareness is expected to drive market growth soon. The lack of blood supply can be met by voluntary blood donation, increasing demand for needles and syringes.
In many developed regions, such as Europe, strict regulations have led to mandatory blood test donations for HIV and HBV infections. As a result, the use of needles for donation and blood testing has increased dramatically in recent years. In addition, according to the Red Cross, demand for blood and blood products is high due to increased cases of complex surgeries, such as chemotherapy, heart surgery, and organ transplantation, which require large numbers of these products.
The increase in needlestick injuries and infections and the increasing use of needleless technology hamper the market growth. In addition, the lack of sufficient physicians in some emerging countries is another significant restraint to the needle market growth.
Impact of COVID-19 on the global needles market:
Coronavirus, a new form of coronavirus, Coronavirus Disease 2019 (COVID-19), was first detected in Wuhan, China, in December 2019. The number of patients continues to rise due to the global outbreak. Many problems associated with injecting drug use, such as viruses, HIV, hepatitis C (HCV), and skin and soft tissue infections, can be prevented and controlled by needle and syringe programs. In addition, more and more individuals are recuperating due to several therapy procedures.
Amid the COVID-19 crisis and impending economic downturn, the global needles market is estimated to showcase a healthy growth rate during the forecast period. The coronavirus pandemic has sparked an unprecedented series of events affecting all industries. As a result, the needles market will be restored to a new normal, which will be continually redefined and rethought in the post-COVID-19 era. Keeping abreast of trends and accurate analyses is more crucial than ever in managing uncertainty, changing, and continuously adapting to new market conditions. Under the new emerging geographic scenario, the United States is expected to re-adjust at a compound annual rate of 6.1%.
The pandemic has been the hardest hit in the Europe region. China, responsible for the pandemic, faces significant political and economic challenges. Amid growing pressure for economic decoupling and distancing, the changing relationship between China and the rest of the world will influence competition and market opportunities. Against this backdrop and changing geopolitical, commercial, and consumer sentiment, the world's second-largest economy will grow 11.3% over the next few years and add approximately USD 953.7 million in affordable market opportunities.
Health institutions have faced syringe and needle shortages since the coronavirus exposed severe weaknesses in the healthcare sector for crucial equipment such as personal protective equipment and ventilators. Needles have been the focus of global vaccine campaigns, with estimates indicating that more than 8 billion needles and syringes would be required for the COVID-19 vaccine alone. Stakeholders are expected to increase capacity and product supply, improving the global market outlook. The development of COVID-19 vaccines has grown due to COVID-19, resulting in an increasing demand for needles.
Market Size Available
2021 to 2027
2022 to 2027
By Type, Product, Delivery Mode, Material, End-User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
This research report on the global needles market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2027.
Needles Market – By Type:
Blunt Fill Needles
Based on the type, the conventional needles segment is forecasted to lead the global needles market during the forecast period. In contrast, bevel needles have been growing faster in recent years. The increasing number of people suffering from severe health issues is fueling the Market's demand. In addition, increasing the need to increase the production rate of needles to meet the hospitals' requirements is prompting the Market's growth.
Needles Market -By Product:
Blood Collection Needles
Based on the product, the suture needles segment is expected to dominate the other segments in the global needles market during the forecast period. This is because increasing incidences of chronic diseases worldwide are making the shares of this segment moving forward. In addition, a rise in the support from private and public organizations in healthcare centers is lavishing the Market's growth rate.
Needles Market – By Delivery Mode:
Needles Market – By Material:
Stainless Steel Needles
Based on material, the stainless steel needles segment has been growing tremendously over the past decade. The rise in awareness over maintaining sterilization while performing surgeries makes the Market hold dominant market shares. Increasing focus on improving treatment procedures is lavishing the demand of the Market.
Needles Market – By End-users:
Hospitals & Clinics
Other End Users
Based on the end-users, the hospitals & clinics segment had the largest share of the needles market in 2021 and is forecasted to continue the lead during the forecast period. Increasing the construction activities of hospitals and rising demand to meet patients' requirements escalate the need for this Market. In addition, the growing priority to provide proper health management for diabetes is gearing up the growth of the needles market.
Needles Market – By Region:
The Middle East and Africa
North American and European regions dominated the global needles market in 2021. It is because of different types of government legislative reforms. The North American needles market held a significant share of the worldwide Market in 2021 and is expected to register a robust CAGR during the forecast period. Y-O-Y, there has been an increase in the prevalence of needle sticks, with the rising population expected to drive market growth in this region. However, the factors such as the availability of safety needles, the active participation of market players, and the rise in the adoption of safety needles propel the market growth in this region during the forecast period. The U.S. needles market is predicted to contribute significantly to this regional Market. Recently, Becton Dickinson, one of the key manufacturers in the needles market, has received many orders from the U.S. and Canadian governments for 177 million needles for COVID-19 vaccination programs. The U.S. majorly invests in the treatment of cancer and diabetes every year. The World Cancer Research Organization 2014 report shows that the number of cancer occurrences in the U.S. was 328 per 100,000, mounting the needle market growth. The Canadian needles market is projected to have a reasonable growth rate during the forecast period. Canadian pharmacies are concentrating more on manufacturing more needles to prevent HIV in patients.
In 2020, the European needles market accounted for the second-largest share globally and was projected to hold a substantial share during the forecast period. Influential growth factors drive the Market in this region. The factors such as developing infrastructure and increasing population increase also contribute to needles' market growth. In addition, encouraging government initiatives and investment funds for developing healthcare standards further create market growth. In Europe, the U.K. needles market is estimated to be growing at a significant rate. To combat COVID-19, the United Kingdom government had ordered Becton Dickinson to deliver 65 million syringes and needles by the mid of September 2020 to assist the U.K. vaccination effort for COVID-19. U.K. is one of the world's first governments to secure vaccine injection devices to support the COVID-19 vaccination campaign.
However, the Asia-pacific needles market is expected to grow at the highest CAGR between 2022 to 2027 due to the increasing geriatric population. Asia Pacific is likely to witness significant growth with a rising Compound Annual growth rate (CAGR) owing to the surge in awareness about the harmful outcomes of needlestick injuries and increasing government initiatives and investments. Moreover, y-o-y, this region is witnessing a high prevalence of chronic and infectious diseases, which is anticipated to propel market growth. In Asia-Pacific, the Japanese needles market is predicted to hold the highest share during the forecast period. Increased adoption of advanced treatment options, lifestyle changes, and medical technology improvements are responsible for the needle market growth in Japan. India is next to Japan as the needles' manufacturing cost is low. Other factors such as rising healthcare expenses, huge patient count, and much knowledge about healthcare are surging India's market growth. China is to have quick changes during the analysis period.
The Latin American Needles Market is estimated to grow steadily from 2022 to 2027 due to the growing need and increasing hospital visits. Among Latin American nations, the Brazilian needles market is projected as the most lucrative region and is expected to register a robust CAGR during the forecast period. The Brazilian government has begun bidding to buy 331 million needles and syringes to battle the COVID-19 vaccination campaign. The Mexican needles market is the world's seventh-largest regional Market in exporting needles and syringes.
The Middle East Africa Needles Market is stable now and is estimated to witness a healthy CAGR during the forecast period. It is expected to improve its growth in the coming years of the forecast period. The increasing prevalence of chronic diseases with the rise in population and availability of advanced treatments augment the Needles market growth.
KEY MARKET PARTICIPANTS AND SHARE INSIGHTS:
Becton Dickinson and Company, B. Braun Melungeon AG, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific are the most influential companies leading the global needles market.
These companies use strategic tactics such as mergers, partnerships, and acquisitions to achieve a larger share of the global economy while still boosting their product portfolio.
RECENT MARKET DEVELOPMENTS:
In September 2020, HTL-STREFA announced Droplet MicronTM, a new and advanced pen needle designed to provide the best injection experience.
In October 2020, Micro-Tech Endoscopy launched the PinPoint Injection Needle.
As per the latest research report published by Market Data Forecast, the global needles market was valued at USD 6.72 billion in 2021.
Regions such as North America, Europe, and APAC are expected to perform well during the forecast period. However, Europe and APAC are predicted to showcase healthy growth rates.
Becton Dickinson and Company, B. Braun Melungeon AG, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific are some of the dominating companies in the global needles market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com